Aglaia BioMedical Ventures

Aglaia is founded on the principle that the willingness to take risks on the very early stage ventures of today results in opportunities

Business Model:

Revenue: $10.1M

Employees: 2-10

Rankings

Industries / Tags:

Detailed Aglaia BioMedical Ventures Information

Geographic Data

Aglaia BioMedical Ventures headquarters map

Address: Professor Bronkhorstlaan 10, building 92

City: Bilthoven

State: other

Zip: 3723

Country: NL

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$65M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Aglaia is founded on the principle that the willingness to take risks on the very early stage ventures of today results in opportunities that may grow into the winning companies of tomorrow. As such, we are typically the first provider of capital for startup and early stage companies and a driving force behind product development. Since the number of technological discoveries in the biomedical field is growing fast, specialized knowledge regarding the translation of these discoveries into novel products is a prerequisite for success. Aglaia&s;s focus on oncology is considered to be a differentiating asset. We invest in novel tools and technologies as well as components of contemporary drug development. Opportunities may be derived from research centers as well as from corporate spinouts. We select, develop and commercialize promising technologies up to a level where the technology becomes attractive to larger investors or pharmaceutical and biotech companies.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
12/2015 Inthera Bioscience Seed Round 0
4/2018 Mimetas Series B 0
12/2015 InteRNA Technologies Series A 0
1/2017 Macrophage Pharma Series A 0
1/2010 Merus Series B 0
1/2017 Cristal Therapeutics Venture Round 0
10/2021 Sapreme Technologies Series A 0
6/2018 Inthera Bioscience Series A 0
2/2021 InteRNA Technologies Series B 0
5/2017 Inthera Bioscience Series A 0
10/2021 Sapreme Technologies Series A 0
2/2021 InteRNA Technologies Series B 0
6/2018 Inthera Bioscience Series A 0
4/2018 Mimetas Series B 0
5/2017 Inthera Bioscience Series A 0
1/2017 Cristal Therapeutics Venture Round 0
1/2017 Macrophage Pharma Series A 0
12/2015 InteRNA Technologies Series A 0
12/2015 Inthera Bioscience Seed Round 0
1/2010 Merus Series B 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research